- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Dermisonics Inc+ Add to Watchlist
DMSI:US0.0052 USD 0.0022 73.33%
As of 17:10:01 ET on 12/24/2014.
Company Profile for Dermisonics Inc (DMSI)
Dermisonics, Inc. is a development stage biotechnology company focused on the development, testing, and commercialization of a transdermal patch. The Company's product has been designed to facilitate the efficient and needle-free delivery of heavy molecular drugs into the system.
Key Executives for Dermisonics Inc (DMSI)
|Bruce H HaglundChairman/Interim CEO & CFO||Bruce K ReddingVP:Licensing & Corp Strategy|